EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Development and Validation of a Novel, Disease‐Specific, Caregiver‐Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported‐Health Index ( DMDCR ‐ HI )

Charlotte Engebrecht iD, Spencer Rosero, Jennifer Weinstein, Jamison Seabury, Anika Varma, Christine Zizzi, John Heatwole, Nuran Dilek, Aaron Kaat, Debra Guntrum, Emma Ciafaloni, Chad Heatwole iD

Muscle & Nerve · 2026-09 · 74 (3) · 623-635

DOI: 10.1002/mus.70327 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Muscle & Nerve, online erschienen am 08.07.2026. Verfasst von Charlotte Engebrecht und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health + Technology (CHeT), University of Rochester Medicine, Rochester, New York, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Caregivers, Patient Reported Outcome Measures. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Muscular Dystrophy Association, Duchenne UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Regulatory‐grade outcome measures are essential for supporting future therapeutic trials. The goal of our study was to develop and validate a multifactorial, disease‐specific, caregiver‐reported outcome (CRO) measure for Duchenne muscular dystrophy (DMD).

Methods

We conducted qualitative interviews and a cross‐sectional study with caregivers of individuals with DMD to determine the most prevalent and impactful symptoms to individuals with DMD. Symptom items were selected for the Duchenne Muscular Dystrophy Caregiver Reported‐Health Index (DMDCR‐HI) based on their prevalence and impact to a national sample cohort of caregivers, along with their potential ability to respond to therapeutics. Subsequently, we conducted cognitive beta interviews, test–retest reliability assessments, and internal consistency analyses to evaluate and optimize the DMDCR‐HI. Using known group analysis, we assessed the ability of the DMDCR‐HI to differentiate between patients with differing levels of disease burden.

Results

The DMDCR‐HI is a regulatory‐grade CRO that comprehensively measures 16 subscales in DMD. The instrument has a high internal consistency, strong test–retest reliability (intraclass correlation coefficient (ICC) = 0.96), and was identified by caregivers as easy to use, relevant, and comprehensive. Through known group analysis, DMDCR‐HI scores demonstrated an ability to differentiate between subgroups with varying levels of symptomatic burden.

Discussion

The DMDCR‐HI is a valid and reliable CRO designed to sensitively and reliably capture how individuals with DMD feel and function from the perspective of the caregiver. The DMDCR‐HI offers a robust mechanism to longitudinally track changes in disease burden in individuals with DMD, regardless of age, cognitive ability, or ambulation status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneCaregiversPatient Reported Outcome MeasuresHumansMaleCross-Sectional StudiesChildReproducibility of ResultsFemaleAdolescentAdultYoung AdultMiddle Aged

Stichwörter der Autor:innen

Duchenne muscular dystrophycaregiver‐reported outcome measureclinical outcome assessmentdrug labelneuromuscular disorder

Autor:innen und Institutionen

  • Center for Health + Technology (CHeT), University of Rochester Medicine, Rochester, New York, USA.
  • University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, Utah, USA.
  • Cornell University, Ithaca, New York, USA.
  • Department of Biostatistics and Neurology, University of Rochester Medicine, Rochester, New York, USA.
  • Department of Medical Social Sciences, Northwestern University, Chicago, Illinois, USA.

ORCID-Profile: Charlotte Engebrecht, Chad Heatwole

Förderung

  • NIGMS NIH HHS
  • Muscular Dystrophy Association
  • Duchenne UK
  • Parent Project Muscular Dystrophy
  • Duchenne Research Fund

Zitieren

APA

Engebrecht, C., Rosero, S., Weinstein, J., Seabury, J., Varma, A., Zizzi, C., Heatwole, J., Dilek, N., Kaat, A., Guntrum, D., Ciafaloni, E., & Heatwole, C. (2026). Development and Validation of a Novel, Disease‐Specific, Caregiver‐Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported‐Health Index ( DMDCR ‐ HI ). Muscle & Nerve, 74(3), 623-635. https://doi.org/10.1002/mus.70327

Vancouver

Engebrecht C, Rosero S, Weinstein J, Seabury J, Varma A, Zizzi C, et al. Development and Validation of a Novel, Disease‐Specific, Caregiver‐Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported‐Health Index ( DMDCR ‐ HI ). Muscle & Nerve. 2026;74(3):623-635. doi:10.1002/mus.70327

BibTeX
@article{Engebrecht2026,
  author = {Engebrecht, Charlotte and Rosero, Spencer and Weinstein, Jennifer and Seabury, Jamison and Varma, Anika and Zizzi, Christine and Heatwole, John and Dilek, Nuran and Kaat, Aaron and Guntrum, Debra and Ciafaloni, Emma and Heatwole, Chad},
  title = {Development and Validation of a Novel, Disease‐Specific, Caregiver‐Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported‐Health Index ( DMDCR ‐ HI )},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {74},
  number = {3},
  pages = {623--635},
  doi = {10.1002/mus.70327}
}
Kostenlos starten →